Cargando…
Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas
Soft tissue sarcomas (STSs) are heterogeneous malignancies derived from mesenchymal cells. Due to its rarity, heterogeneity, and limited overall response to chemotherapy, STSs represent a therapeutic challenge. Necroptosis is a novel therapeutic strategy for enhancing immunotherapy of cancer. Nevert...
Autores principales: | Qi, Lin, Xu, Ruiling, Ren, Xiaolei, Zhang, Wenchao, Yang, Zhimin, Tu, Chao, Li, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159500/ https://www.ncbi.nlm.nih.gov/pubmed/35663937 http://dx.doi.org/10.3389/fimmu.2022.877815 |
Ejemplares similares
-
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2022) -
Identification and Validation of a Novel Pyroptosis-Related Gene Signature for Prognosis Prediction in Soft Tissue Sarcoma
por: Qi, Lin, et al.
Publicado: (2021) -
Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas
por: Xu, Ruiling, et al.
Publicado: (2022) -
Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023) -
Intratumoral STING activation causes durable immunogenic tumor eradication in the KP soft tissue sarcoma model
por: Marritt, Kayla L., et al.
Publicado: (2023)